Total Payments
$27,053
2024 Payments
$2,087
Companies
41
Transactions
969
Medicare Patients
2,007
Medicare Billing
$550,217
Payment Breakdown by Category
Food & Beverage$15,991 (59.1%)
Consulting$7,313 (27.0%)
Travel$2,196 (8.1%)
Other$1,500 (5.5%)
Education$53.76 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,991 | 955 | 59.1% |
| Consulting Fee | $7,313 | 2 | 27.0% |
| Travel and Lodging | $2,196 | 8 | 8.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 1 | 5.5% |
| Education | $53.76 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $11,549 | 79 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $1,841 | 22 | $0 (2018) |
| ABBVIE INC. | $1,776 | 138 | $0 (2024) |
| PFIZER INC. | $1,488 | 95 | $0 (2024) |
| Amgen Inc. | $1,293 | 72 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $1,161 | 74 | $0 (2024) |
| CSL Behring | $973.21 | 42 | $0 (2022) |
| Allergan, Inc. | $941.00 | 53 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $790.83 | 73 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $752.04 | 47 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,087 | 132 | PFIZER INC. ($707.45) |
| 2023 | $1,767 | 113 | PFIZER INC. ($664.50) |
| 2022 | $2,025 | 111 | Biohaven Pharmaceutical Holding Company Ltd. ($540.35) |
| 2021 | $2,057 | 119 | Biohaven Pharmaceuticals, Inc. ($359.75) |
| 2020 | $1,996 | 126 | CSL Behring ($304.93) |
| 2019 | $2,103 | 157 | Zyla Life Sciences ($318.99) |
| 2018 | $6,970 | 120 | Lilly USA, LLC ($5,386) |
| 2017 | $8,048 | 91 | Lilly USA, LLC ($5,087) |
All Payment Transactions
969 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Central Nervous System | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: PAIN | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: PAIN | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: PAIN | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: Neurology | ||||||
| 11/19/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Neuromodulation | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: PAIN | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: PAIN | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Central Nervous System | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 368 | 21,135 | $536,810 | $146,001 |
| 2022 | 13 | 466 | 16,879 | $481,093 | $135,319 |
| 2021 | 13 | 585 | 15,556 | $502,152 | $145,005 |
| 2020 | 13 | 588 | 12,678 | $444,067 | $123,892 |
Total Patients
2,007
Total Services
66,248
Medicare Billing
$550,217
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 33 | 20,665 | $389,393 | $100,205 | 25.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 33 | 93 | $38,223 | $10,941 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 87 | $18,183 | $7,987 | 43.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 58 | 88 | $24,464 | $6,724 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $13,566 | $5,687 | 41.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 22 | 22 | $16,192 | $3,441 | 21.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $8,610 | $3,203 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 47 | $6,674 | $3,036 | 45.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 13 | 14 | $12,082 | $2,681 | 22.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 13 | 13 | $7,904 | $1,801 | 22.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 31 | $1,519 | $294.75 | 19.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 32 | 16,325 | $300,107 | $78,270 | 26.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 81 | 124 | $34,472 | $10,104 | 29.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 29 | 72 | $29,592 | $8,625 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 87 | $18,183 | $8,203 | 45.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $14,364 | $5,723 | 39.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 68 | 68 | $14,280 | $5,670 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 65 | $9,230 | $4,486 | 48.6% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 19 | 19 | $16,397 | $3,857 | 23.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 20 | 21 | $15,456 | $3,739 | 24.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 17 | 19 | $11,552 | $2,748 | 23.8% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 11 | 11 | $11,011 | $2,486 | 22.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 13 | 13 | $5,993 | $1,353 | 22.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 16 | 19 | $456.00 | $56.43 | 12.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 31 | 14,855 | $267,836 | $71,245 | 26.6% |
About Dr. Marci Roy, M.D
Dr. Marci Roy, M.D is a Neurology healthcare provider based in Kyle, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457356073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marci Roy, M.D has received a total of $27,053 in payments from pharmaceutical and medical device companies, with $2,087 received in 2024. These payments were reported across 969 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($15,991).
As a Medicare-enrolled provider, Roy has provided services to 2,007 Medicare beneficiaries, totaling 66,248 services with total Medicare billing of $550,217. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Kyle, TX
- Active Since 06/20/2005
- Last Updated 01/09/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1457356073
Products in Payments
- NURTEC ODT (Drug) $2,202
- ONZETRA Xsail (Drug) $1,827
- Aimovig (Biological) $1,118
- EMGALITY (Drug) $1,109
- Hizentra (Biological) $973.21
- BOTOX (Biological) $946.33
- AJOVY (Biological) $885.47
- UBRELVY (Drug) $765.30
- TROKENDI XR (Drug) $753.45
- QULIPTA (Drug) $668.82
- AIMOVIG (Biological) $595.83
- SPRIX (Drug) $416.87
- ZOMIG (Drug) $302.31
- SOLIRIS (Drug) $274.91
- VYEPTI (Biological) $239.34
- AJOVY (Drug) $219.53
- Zembrace (Drug) $203.83
- Gamunex-C (Biological) $196.65
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $167.43
- GILENYA (Drug) $156.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.